SBH
ORGO icon

Segall Bryant & Hamill’s Organogenesis Holdings ORGO Stock Holding History

Segall Bryant & Hamill’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-319,322
Closed -$1.65M – 627
2025
Q4 		$1.65M Buy
319,322
+597
+0.2% +$2.89K 0.02% 463
2025
Q3 		$1.35M Sell
318,725
-2,481
-0.8% -$11.5K 0.02% 473
2025
Q2 		$1.18M Buy
+321,206
New +$1.2M 0.02% 489

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Segall Bryant & Hamill's ORGO Position: Q1 2026 in Review

Segall Bryant & Hamill sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 319,322 shares — an estimated $1.65M sold.

Segall Bryant & Hamill first reported a position in ORGO in Q2 2025 and held it in 3 quarters. The position peaked at $1.65M in Q4 2025. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • Segall Bryant & Hamill reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
  • Segall Bryant & Hamill sold 319,322 Organogenesis Holdings shares in Q1 2026, an estimated $1.65M.
  • Segall Bryant & Hamill first reported a position in Organogenesis Holdings in Q2 2025 and held it in 3 quarters.
  • Segall Bryant & Hamill's Organogenesis Holdings position peaked at $1.65M in Q4 2025.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Segall Bryant & Hamill's 13F filing for Q1 2026, filed 15 May 2026.